COVID-19 Resources

Critical COVID-19 Vaccine Update

The Ohio AAP knows many of our members who work on the front lines are still waiting to receive the COVID-19 vaccine and are wondering when they can expect to receive it. Ohio AAP leadership has been working hard to address this issue through weekly calls with the Ohio Department of Health to advocate for community pediatricians to receive the vaccine through the hospitals. We will continue to advocate and keep you updated as we learn more.
*Each health department is handling vaccinations through different systems – some through online sign ups, others through appointments. Please contact your local health department to be put on the list to vaccinate yourself and your staff.                                     To Find & Contact Your Local Health Department

Updates from the Ohio Department of Health for Vaccine Providers

*Please note, this section will be updated as we receive updates and news from the Ohio Department of Health. Please refer here to see the latest in communications.

February 16, 2021: COVID-19 Vaccine Town Halls for At-Risk Populations to Address Vaccine Hesitancy
(Click above to expand)

Health/Medical/Public Health/Pharmacy/Health Plan/Long-Term Care Association Partners,

The Ohio Department of Health and the Ohio Department of Mental Health and Addiction Services have scheduled a series of COVID-19 Vaccine Town Halls with medical experts, community leaders, and public health professionals to address common concerns and questions among specific populations. As Ohio continues to roll out the COVID-19 vaccine, sharing accurate, reliable information with at-risk populations to help reduce vaccine hesitancy remains a high priority.

We are asking for your help by sharing this information with your members and encouraging them to promote these Town Halls with their patients/stakeholders.

A toolkit is available for download to help promote the Town Halls at https://coronavirus.ohio.gov/static/vaccine/town_hall_communications_toolkit.pdf. In addition, a graphics package of web banners, fliers, social media graphics, and web advertisements is linked within the toolkit and is accessible here.

 The Town Hall schedule for at-risk populations is as follows:

  • Monday, February 22, 6:30 p.m. – African American Ohioans
  • Tuesday, Feb. 23, 6:30 p.m. – Hispanic/Latino Ohioans
  • Monday, March 1, 6:30 p.m. – Asian American and Pacific Islander Ohioans
  • Tuesday, March 2, 6:30 p.m. – Rural Ohioans

Thank you for your assistance in spreading the word about these Town Halls so that we can share accurate, reliable information with at-risk populations to help reduce vaccine hesitancy.

Regards,

Russ Kennedy

Deputy Director for External Affairs

January 14, 2021: Enrolled COVID-19 Vaccination Providers Webinar re Phase 1B Overview
(Click above to expand)

Thank you for joining the Ohio Department of Health (ODH) on Monday, January 11 for a webinar to give Ohio’s 2,000+ enrolled vaccination providers an overview of our Phase 1B vaccination strategy and the important role that many of you will play in vaccinating priority populations. A guidance document is attached outlining what providers need to know about Phase 1B of COVID-19 vaccine distribution.

Phase 1B starts next week (week of January 18). If you were not able to attend the webinar, it is critical that you watch a recording to learn what role you may play as a vaccination provider in Phase 1B and expectations of you.

The recording is available at https://cisco.webex.com/recordingservice/sites/cisco/recording/5732bceb03384d0e946774784bda85fe/playback. You may receive a message about downloading/decrypting taking a few moments. Afterward, although the screen will read “There is no content to view at the moment..” press the “play” button on the toolbar in the lower left corner of the screen. It will take about 12 seconds before the webinar moderator begins to speak.

In addition to the recording, the following resources are linked below: 

The webinar invitation was sent to each enrolled provider’s primary contact person and backup contact person designated at enrollment. Because of the importance of this communication, we are sending this post-webinar email and information to these individuals, as well as to provider leadership contacts identified on enrollment applications.

Highlights from the webinar include:

  • Phase 1B starts the week of January 18 and will focus on vaccinating Ohioans age 80 and older.
    • Five-year age groups will be phased in each week thereafter (i.e., 75+, 70+, and 65+).
    • Individuals age 18 and older (Moderna vaccine) or age 16 and older (Pfizer-BioNTech vaccine) with severe congenital, developmental, or early onset medical disorders that make them particularly vulnerable will be eligible for vaccination beginning the week of January 25.
    • K-12 teachers and staff in schools that commit to returning to full in-class or hybrid learning by March 1 will be eligible for vaccination beginning the week of February 1.
  • Not all Phase 1B providers will be allocated vaccine initially, and allocations will be made on a rolling basis as vaccine becomes available.
  • Providers who will receive a vaccine shipment the week of January 18 received an email notification (including number of doses) on Tuesday, January 12. The email was sent to the primary contact person your enrolled site(s) designated on its/their enrollment application.
    • These shipments will arrive between Monday and Wednesday, January 18 – 20.
  • For future vaccine shipments, providers who will receive additional vaccine will get an email notification from ODH in advance. This email will be sent to the primary contact person and backup contact person your enrolled site(s) designated on its/their enrollment application.
  • The number of doses allocated to providers will be limited while the vaccine supply remains limited.
  • Providers receiving vaccine are expected to be prepared to start administering it within 24 hours of receipt.
  • Providers are expected to use all of their vaccine supply within 7 days of receipt.
  • Allocations were made based on Phase 1B population (80+ year olds) within the county – and vaccines should be administered in the same county.
  • It is ODH’s expectation that providers make vaccine available to the public, e.g., do not only provide vaccine to your existing patient panel.
  • The state is adding a search function on its coronavirus website so eligible Ohioans can find where to get vaccinated.
    • Providers must submit vaccine administration location addresses, phone numbers, and website to the state by logging into their OHID account (same account used to enroll as a COVID-19 vaccination provider) at http://bit.ly/SubmitProviderLocation
  • A broad range of COVID-19 vaccination training materials, tools, and resources are available on the ODH website at https://odh.ohio.gov/wps/portal/gov/odh/know-our-programs/covid-19-vaccine-provider/covid-19-vaccine-provider-training.

Please watch the webinar for more detailed information about these and other issues.

January 13, 2021: Share Your Information for New COVID-19 Vaccine Provider Directory
(Click above to expand)

To Enrolled Vaccine Provider Partners,

This is a reminder that your urgent action is required to be included in a new statewide COVID-19 vaccine provider search that will be available at coronavirus.ohio.gov/vaccine beginning tomorrow, Jan. 14.

To provide your contact information for the new Vaccine Provider Locations directory, click here.

This vital new resource will help Ohioans eligible to receive vaccine during Phase 1B  locate a provider in their area. The directory will show all enrolled COVID-19 vaccination providers currently administering vaccines to Phase 1B populations throughout Ohio. The public will be able to search for a provider by county, ZIP code, or category.

HOW TO SUBMIT YOUR INFORMATION

Complete this brief form at https://ohid.ohio.gov/wps/myportal/gov/covidvac/locations/vaccine-administration. This is a part of the Vaccination Provider Program (COVID-19) app.

Step-by-step instructions:

  1. Click on the form link. This will prompt you to log into your OHID account.
    • This is the account you created to enroll as a vaccine provider.
    • If you are a new user, create an account, and request access to the Vaccination Program (COVID-19) application to begin enrollment as a vaccine provider.
  2. Once you land on the Vaccine Administration Locations page, click the Add Location(s) form.
  3. Click on your name and Terminal Distributor of Dangerous Drugs (TDDD) license number in the dropdown menu.
    • To find your (TDDD) license number, please visit the State of Ohio Board of Pharmacy website.
    • If you cannot find your name and (TDDD) in the dropdown, you must complete and submit a Section A and Section B form to complete enrollment as a vaccine provider. Once your Section B form is reviewed, and enrollment is complete, your facility will appear in the dropdown for this form.
  4. Enter the following information:
    • Name of vaccine administration site.
    • Address of vaccine administration location, including city, ZIP code, and county. (Note, this is the address of the location the public will go to receive the vaccination, not the shipment address.)
    • Phone number(s) for patients to call to schedule a vaccine appointment if eligible.
    • Website for patients to schedule an appointment or find more information.
    • If you need to add other locations, click the Add Another Location button. Repeat the process above for all administration sites.
    • Click Submit Location(s) Entries.

If you have any technical issues accessing your OHID account or completing the process above, contact the Office of Management Information Systems (OMIS) Help Desk at HelpStar@odh.ohio.gov or 614-752-5190.

For other inquiries, please call the ODH Provider Call Center between 8  a.m. – 7 p.m. Monday through Friday, and 8 a.m. – 5 p.m. Saturday and Sunday, at 1-844-9ODHVAX (1-844-963-4829) or email COVIDVACCINE@odh.ohio.gov. You also may visit the ODH COVID-19 Vaccine Provider Information Training page for additional information and resources

January 7, 2021: Ensuring the COVID-19 Vaccine is Not Wasted
(Click above to expand)

Enrolled COVID-19 Vaccination Provider Partners,

The Ohio Department of Health (ODH) offers the following additional guidance for ensuring COVID-19 vaccine is not wasted. In order to mitigate the risk of wasting COVID-19 vaccine, providers should attempt to verify the number of vaccine recipients immediately prior to each scheduled clinic.

To prevent vaccine wastage in the event that you have excess vaccines upon completion of a vaccination clinic and those vaccines are set to expire, it is critically important that providers have a plan in place to immediately identify and administer vaccine to backup recipients. Many providers have implemented waiting lists of eligible individuals for such circumstances.

To the extent possible, ODH advises that providers administer excess vaccines in the following priority order:

  1. Identify Phase 1A eligible individuals to administer the vaccine to (healthcare providers, EMS personnel, or congregate care residents/staff).
  2. Identify Phase 1B eligible individuals to administer the vaccine to (individuals age 65+, people with severe congenital, developmental, or early onset medical disorders that make them particularly vulnerable, and teachers/staff in K–12 schools that plan to return to in-person classes in March).
  3. Identify otherwise eligible adults not included in Phases 1A or 1B to administer the vaccine to (e.g., priority to adults with underlying medical conditions before adults with no underlying medical conditions).
  4. If more than 20 doses are at risk of wastage, please call the ODH Provider Call Center at the number below to discuss options including, but not limited to, transfer of vaccine to other enrolled providers.

 IMPORTANT:  To prevent wastage of COVID-19 vaccine, providers should have a backup recipient plan in place. Where possible, follow the priority guidance outlined above. When not possible due to time constraints or lack of availability of priority individuals, please administer vaccine to any individuals eligible under the appropriate FDA Emergency Use Authorization (EUA).

As noted in previous guidance on this issue, if you administer vaccinations under the circumstances outlined above:

  • The vaccine administration must be reported in ImpactSIIS, including race and ethnicity data, within 24 hours.
  • Target population/occupation data does not need to be reported for vaccinated individuals not in Phase 1A.
  • Be sure to include these vaccinated individuals in your follow-up plans for administering second doses.

If you have any questions or issues, please call the ODH Provider Call Center between 8:00 a.m. – 7:00 p.m. Monday through Friday, and 8:00 a.m. – 5:00 p.m. Saturday and Sunday, at 1-844-9ODHVAX (1-844-963-4829) or email COVIDVACCINE@odh.ohio.gov. You also may visit the ODH COVID-19 Vaccine Provider Information Training page for additional information and resources

Sincerely,

ODH COVID-19 Vaccination Provider Relations Team


COVID-19 Vaccine Information 

Share the following information with your patients and their families to highlight the importance and safety of receiving the COVID vaccine! 

Why should you get the COVID vaccine?

While taking precautions such as wearing masks and maintaining social distance of 6 feet apart is effective in reducing the spread of COVID, completely stopping a pandemic requires using all tools available! The COVID vaccine works with your immune system to make sure your body will be ready to fight the virus if you are exposed. Using all available means, including the COVID vaccine will help us fight COVID and stop further spread. 

FAQs with Ohio AAP TIES Medical Director, Bob Frenck, MD, FAAP
(Click above to expand)
  1. What is the youngest age that will be able to receive any of the COVID-19 vaccines? Currently, the youngest is 12 years of age. However, we have been sent protocols from 2 different Sponsors with the age going down to 5 years of age. Some companies have talked about going down to 12 months or less, but no protocols have yet been sent.
  2. Any thoughts or predictions on WHEN we will start vaccinating kids? The clinical trials for children will likely start in late Winter to early Spring. In children, we are doing “Immunological bridging studies” – the numbers will be smaller and results available sooner (maybe within 2-3 months of enrolling). Thus, I still think it possible that we will have licensed vaccines for at least some pediatric age groups before the 2021-2022 school year.
  3. What about patients who have tested positive whether symptomatic or not OR have positive antibodies – is there a plan whether they will be able to receive the vaccine? Good question. That still needs to be decided. From small scale studies in adults, the frequency and type of side effects were the same whether or not you already had COVID-19.
  4. Where do Pediatricians fall in the distribution? I think all health care providers seeing patients are seen as a single category. But the final decisions will come from the State Health Departments. The decision will also partly depend on how many doses of vaccine are available.
  5. When will they use this same vaccine technology to come up with a universal influenza vaccine? That would be great! One thing in favor of the COVID-19 vaccine is that the spike protein seems to be essential to the virus. The essential protein for flu looks to be the stalk protein. However, it has been difficult to get a good antibody against the stalk protein. Maybe new technologies will improve our ability to make a vaccine against the stalk protein.
  6. Can you tell us more about the very low temperatures needed to keep the vaccines stable? Pfizer informed us that they are currently looking at the stability of the vaccine at warmer temps. My guess is we will find that the Pfizer vaccine will have storage requirements similar to Moderna. However, tests will need to be conducted to be sure.
  7. What temperatures are needed to store vaccines? Currently, Pfizer is listed as -70C, Moderna is -20C, and Astra Zeneca is refrigerated. However, I think companies will be looking at the ability to safely store the mRNA vaccines at warmer temps and there will be a workable solution as to the storage requirements.
  8. How do you recommend talking to families about potential long term risks that can’t be known yet due to the vaccine creation timeline? All the vaccines are targeting the spike protein. The mRNA vaccines are using mRNA that is degraded soon after it is translated into spike protein. So, there should not be any long term effects of the mRNA. The Astra Zeneca vaccine is using an adenovirus that is replication incompetent, meaning that the virus can’t live and grow in us. The Sanofi and NovaVax vaccines are protein vaccines, very similar to the flu vaccine. The end result is that while the technology is new, there is no evidence to indicate there is long term harm from the vaccine candidates.
  9. Are you concerned about how polarized the public is about science, especially prevention including vaccines? I am concerned about the general breakdown in the trust of science and how Public Health measures are being viewed as political issues instead of safety issues. However, we need to keep up the fight and continue to be strong advocates for the health of children, particularly preventive medicine such as vaccines. If we don’t keep up the campaign to educate and inform parents, we will be putting the health of children at risk. 

Email us if you don’t see your question already here!

True or False: Busting Myths about COVID-19 Vaccines

COVID Vaccination Communication Toolkits from the CDC: Designated toolkits for providers, clinics and more to educate and build vaccine confidence. 

Vaccine Hesitancy Communication: Communication skills for talking about COVID vaccines


ODH Guidance on COVID-19 Vaccination Provider Enrollment

Ohio AAP COVID-19 Webinars & Podcasts

For Providers


Immunization Resources


For Parents 

For School Nurses & School Staff 


Media Updates